Stan Karbowiak: ‘The Man With the Golden Arm’ Changed the Fate of Millions of Babies
Stan Karbowiak, CEO and Founder – Medical and Wellness Information Specialist at MyHealthCRM, shared a post on LinkedIn:
“James Harrison’s story begins when he was a teenager recovering from major chest surgery in the 1950s, during which he received large amounts of donated blood to survive.
That experience left him determined to ‘give back’ once he was old enough to donate himself.
When he finally did, doctors discovered something extraordinary in his plasma: a rare antibody known as anti‑D, likely formed because of the transfusions he received as a boy.
This antibody turned out to be the key to preventing Rhesus disease, a condition that once caused thousands of newborn deaths each year.
Throughout the next six decades, Harrison donated plasma as often as Australian guidelines allowed, every two weeks, ultimately reaching 1,173 donations before mandatory age limits forced him to stop at 81.
His plasma was used to create ‘RhoGAM‑type injections’, which protect Rh‑negative mothers from developing antibodies that could attack their unborn babies.
Before this treatment existed, many women lost multiple pregnancies; after it became widespread, infant mortality from Rhesus disease plummeted across Australia.
Because his antibodies were so uniquely effective, Harrison became known nationwide as ‘The Man with the Golden Arm,’ and his donations are credited with saving over 2.5 million babies, a number so large that entire generations owe their lives to him.
Despite the fame, he remained humble, treating each donation like a simple errand rather than a heroic act. His legacy continues today through other anti‑D donors and ongoing research into lab‑made monoclonal antibodies that may one day replace the need for rare individuals like him.”
Stay updated with Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers